What is the survival rate for triple negative metastatic breast cancer?

Can you survive triple negative?

The five-year survival rate for someone with localized triple-negative breast cancer, cancer that has not spread beyond the breast, is 91 percent (91 percent as likely as someone without cancer to survive during the five-year period).

What does survival rate of 5 years mean?

The percentage of people in a study or treatment group who are alive five years after they were diagnosed with or started treatment for a disease, such as cancer. The disease may or may not have come back.

Is TNBC hereditary?

The higher incidence of TNBC in certain populations such as young women and/or women of African ancestry and a unique pathological phenotype shared between TNBC and BRCA1-deficient tumors suggest that TNBC may be inherited through germline mutations.

Does triple-negative always come back?

Recurrence. Although triple-negative breast cancer is more likely to return to another part of your body than other forms, the risk that this will happen drops over time. The risk peaks around 3 years of treatment and falls quickly after that.

What is the success rate of chemotherapy?

Five years after treatment, the rate of overall survival was 98.1% for those who had chemo and 98.0% for those who did not. Nine years after treatment, the rate of overall survival was 93.8% for those who had chemo and 93.9% for those who did not.

THIS IS INTERESTING:  Is the Depo shot linked to cancer?

What is a ten year survival rate?

The measure ’10-year survival at diagnosis’ is defined as the ratio of the proportion of people who are still alive at 10 years after diagnosis of their cancer (observed survival) divided by the proportion of people in the general population expected to survive the same time interval (expected survival) after matching …

What is median survival time?

Listen to pronunciation. (MEE-dee-un oh-ver-AWL ser-VY-vul) The length of time from either the date of diagnosis or the start of treatment for a disease, such as cancer, that half of the patients in a group of patients diagnosed with the disease are still alive.